Wednesday, May 29, 2024
English English French Spanish Italian Korean Japanese Russian Hindi Chinese (Simplified)

Muscat – The Ministry of Health (MoH), in cooperation with the National Committee for Narcotics and Psychotropic Substances, on Wednesday launched an awareness programme in Dhahirah governorate on the harms of narcotic drugs and psychotropic substances.

The three-day programme brings together government employees, charity workers, sportspersons, and health workers from three wilayats – Ibri, Yanqul and Dhank.

“The programme includes several axes reviewing the current situation of drug abuse issues and the national efforts in combating these influences; as well as the therapeutic services available in the rehabilitation of addicts in order to help them return to normal life and engage in a healthy society,” said Dr Laila Ali al Kalbaniya, head of the department of health education and community health initiatives in Dhahirah.

According to Dr Laila, the programme aims to enhance awareness to reduce the phenomenon of drug and psychotropic substance abuse and raise awareness of the social and psychological effects resulting from it.

She highlighted the role of the family in preventing and addressing this phenomenon and the importance of following up children at an early age to protect them from getting addicted to drugs and psychotropic substances.

“The joint efforts of the relevant institutions will help raise awareness,” she added.


* indicates required

The Enterprise is an online business news portal that offers extensive reportage of corporate, economic, financial, market, and technology news from around the world. Visit to explore daily national, international & business news, track market movements, and read succinct coverage of significant events. The Enterprise is also your reach vehicle to connect with, and read about senior business executives.

Address: 150th Ct NE, Redmond, WA 98052-4166

©2024 The Enterprise – All Right Reserved.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept